EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+5.81%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$947M
AUM Growth
+$947M
(-15%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-14.16%
Top 10 Holdings %
Top 10 Hldgs %
57.65%
Holding
77
New
15
Increased
20
Reduced
27
Closed
7
Top Buys
| 1 |
Inspire Medical Systems
INSP
|
$26.8M |
| 2 |
HCA Healthcare
HCA
|
$16M |
| 3 |
Bio-Techne
TECH
|
$12.6M |
| 4 |
Krystal Biotech
KRYS
|
$12.5M |
| 5 |
ABCM
Abcam plc American Depositary Shares
ABCM
|
$12.2M |
Top Sells
| 1 |
Biogen
BIIB
|
$42.8M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$35.4M |
| 3 |
GSK
GSK
|
$30.6M |
| 4 |
Natera
NTRA
|
$19.8M |
| 5 |
AMED
Amedisys
AMED
|
$16.5M |
Sector Composition
| 1 | Healthcare | 98.52% |
| 2 | Communication Services | 0.83% |
| 3 | Financials | 0.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TARO
26
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $9.49M | 0.79% |
250,286
+5,019
| +2% | +$190K |
|
27
Repligen
RGEN
$6.54B
| $9.35M | 0.78% |
66,067
+60,411
| +1,068% | +$8.55M |
|
28
InflaRx
IFRX
$117M
| $8.54M | 0.71% |
+1,915,113
| New | +$8.54M |
|
29
NewAmsterdam Pharma
NAMS
$2.8B
| $8.23M | 0.69% |
692,369
+646,513
| +1,410% | +$7.69M |
|
|
MODN
30
DELISTED
MODEL N, INC.
MODN
| $7.89M | 0.66% |
223,168
-18,702
| -8% | -$661K |
|
31
Liquidia Corp
LQDA
$2.52B
| $7.26M | 0.61% |
925,444
+201,038
| +28% | +$1.58M |
|
32
Xenon Pharmaceuticals
XENE
$2.99B
| $6.6M | 0.55% |
171,378
-31,894
| -16% | -$1.23M |
|
33
Molina Healthcare
MOH
$9.6B
| $6.4M | 0.54% |
+21,254
| New | +$6.4M |
|
34
Puma Biotechnology
PBYI
$258M
| $5.85M | 0.49% |
1,658,195
-279,893
| -14% | -$988K |
|
|
SWAV
35
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $5.75M | 0.48% |
20,138
-27,439
| -58% | -$7.83M |
|
36
Humana
HUM
$37.5B
| $5.34M | 0.45% |
11,927
-10,835
| -48% | -$4.85M |
|
37
Pennant Group
PNTG
$853M
| $5.3M | 0.44% |
431,622
+9,648
| +2% | +$118K |
|
38
Apellis Pharmaceuticals
APLS
$3.51B
| $5.14M | 0.43% |
+56,449
| New | +$5.14M |
|
39
Kura Oncology
KURA
$732M
| $4.77M | 0.4% |
+450,622
| New | +$4.77M |
|
40
IQVIA
IQV
$31.4B
| $4.21M | 0.35% |
18,748
+4,332
| +30% | +$974K |
|
41
eHealth
EHTH
$126M
| $4.04M | 0.34% |
503,079
-731,204
| -59% | -$5.88M |
|
42
Medpace
MEDP
$13.5B
| $3.74M | 0.31% |
15,564
+3,896
| +33% | +$936K |
|
43
CureVac
CVAC
$1.21B
| $3.72M | 0.31% |
+357,342
| New | +$3.72M |
|
44
Sutro Biopharma
STRO
$85.6M
| $3.48M | 0.29% |
+747,912
| New | +$3.48M |
|
45
Merus
MRUS
$5.04B
| $3.46M | 0.29% |
131,226
+2,170
| +2% | +$57.1K |
|
46
Agilent Technologies
A
$35.5B
| $3.43M | 0.29% |
28,460
+15,350
| +117% | +$1.85M |
|
47
Protagonist Therapeutics
PTGX
$3.62B
| $3.17M | 0.26% |
+114,659
| New | +$3.17M |
|
48
Biohaven
BHVN
$1.71B
| $3.14M | 0.26% |
131,103
-54,492
| -29% | -$1.3M |
|
|
PRTK
49
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $2.93M | 0.25% |
1,327,857
+689,383
| +108% | +$1.52M |
|
50
Waters Corp
WAT
$17.3B
| $2.91M | 0.24% |
+10,928
| New | +$2.91M |
|